홈
마켓
차트 & 아이디어
Algo
뉴스
Store
브로커
다운로드
경제 달력
트레이딩 시그널
웹터미널
Heatmap
검색
/
타입: @user, $symbol
검색
로그인
계정을 생성하십시오
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
VERA
#1665
Vera Therapeutics, Inc. Class A Common Stock
44.360
0
USD
+1.49%
부문:
헬스케어
베이스:
USD
수익 통화:
USD
일일 변동 비율
년간 변동
일일 변동
+1.49%
월간 변동
+9.34%
6달 변화
+49.16%
년간 변동율
+49.16%
이전 종가
43.710
0
Open
44.360
0
Bid
Ask
Low
44.360
0
High
44.360
0
양
115
마켓
주식
헬스케어
VERA
Open full chart
Financials
Overview
성명
Statistics
Quarterly
Annual
Value
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
26.74 M
44.26 M
54.45 M
63.75 M
71.36 M
—
Valuation ratios
Enterprise value
657.09 M
797.81 M
858.02 M
2.66 B
3.35 B
8.29 B
Price to earnings ratio
—
-5.46
-6.94
-15.38
-10.87
-32.74
Price to sales ratio
—
127.06
175.21
601.64
7 992.14
9 671.46
Price to cash flow ratio
—
-7.19
-7.23
-17.37
-13.49
-38.61
Price to book ratio
—
6.32
6.56
4.05
5.5
7.94
EBITDA 비율에 대한 기업 가치
—
—
—
-15.95
-21.89
-42.65
Profitability ratios
Return on assets %
-0.39
-0.68
-0.55
-0.23
-0.41
-0.5
Return on equity %
-0.47
-1.16
-0.94
-0.26
-0.5
-0.61
Return on invested capital %
-8 665.23
-7 294.2
-5 690.71
-11.23 K
-20.44 K
—
Gross margin %
100
100
100
100
100
400
Operating margin %
-1 278.41
-2 375.31
-2 681
-4 298.53
-77.51 K
12.86 K
EBITDA margin %
—
—
—
-4 195.83
-77.3 K
13.24 K
Net margin %
-1 211.78
-2 327.04
-2 522.73
-3 912.27
-73.62 K
12.8 K
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
10.73
4.91
7.71
25.67
13.64
70.55
Inventory turnover
—
—
—
—
—
—
Asset turnover
0.03
0.04
0.02
0.01
0
0
Solvency ratios
Debt to assets ratio
0.17
0.24
0.31
0.08
0.11
0.48
Debt to equity ratio
0.2
0.41
0.53
0.09
0.13
0.59
Long term debt to total assets ratio
0.06
0.19
0.28
0.08
0.1
0.46
Long term debt to total equity ratio
0.07
0.32
0.49
0.09
0.12
0.57
Per share metrics
Operating cash flow per share
—
-2.54
-2.16
-2.43
-3.75
-3.77
EBIT per share
—
-3.28
-2.3
-2.95
-4.9
-4.93
EBITDA per share
—
—
—
-2.95
-4.9
-4.92
Total debt per share
—
1.18
1.26
0.99
1.2
4.48
Cash per share
—
4.32
3.76
11.58
11.12
36.91
Net current asset value per share
—
4.73
4.03
11.77
11.35
37.83
Tangible book value per share
—
2.89
2.38
10.43
9.21
31.2
Working capital per share
—
3.77
3.51
11.31
10.52
35.47
Book value per share
—
2.89
2.38
10.43
9.21
31.2
뉴스
베라 테라퓨틱스, Wolfe Research, 투자의견 상향 조정
Wolfe Research upgrades Vera Therapeutics stock rating on valuation
베라 테라퓨틱스, BofA 증권 ’매수’ 등급 재확인
Vera Therapeutics stock rating reaffirmed at Buy by BofA Securities
Vera Therapeutics, Inc. (VERA) Presents at TD Cowen 46th Annual Health Care Conference Transcript
베라 테라퓨틱스, 이사회에 크리스토퍼 하이트 선임
Vera Therapeutics adds Christopher Hite to board of directors
3 Best Stocks With 125%+ Upside Ahead, According to Top Analysts, 3/2/2026 - TipRanks.com
Vera Therapeutics: Hold Rating Based On Potential For Atacicept In IgAN (Rating Downgrade)
VeraDermics is said to draw IPO anchor order from Eli Lilly - Bloomberg
베라 테라퓨틱스, Matt Skelton을 최고 상업 책임자로 승진 임명
Vera Therapeutics promotes Matt Skelton to chief commercial officer